Afib Ablation Exceeds Expectations in Sickest Heart Failure Patients
AMSTERDAM — Catheter ablation conferred large clinical benefits to people with end-stage heart failure and symptomatic atrial fibrillation (Afib) in the small CASTLE HTx randomized trial that was terminated prematurely for efficacy. The trial, originally planned for 2 years, was brought to a halt upon the discovery that these patients undergoing catheter ablation had fewer […]
Reassuring Findings on Bivalent COVID Booster in Hemodialysis Patients
Anti-spike IgG concentrations against BA.4/5 significantly increased in patients with end-stage renal disease (ESRD) following a bivalent booster, particularly in those without a prior Omicron infection, a case series from Germany found. The study looked at 55 ESRD patients on hemodialysis who had received four prior doses of a monovalent vaccine, including about a third […]